CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Hangzhou Alltest Biotech Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Hangzhou Alltest Biotech Co Ltd
Factory Building No. 3, 4, & 5, No. 550
Yinhai Street, Baiyang Neighborhood
Phone: +86 57156207860p:+86 57156207860 HANGZHOU, ZHJ  310018  China Ticker: 688606688606
Business Summary
Hangzhou Alltest Biotech Co Ltd is a China-based company mainly engaged in the development and production of in vitro diagnostic reagents. The Company’s main products are rapid diagnostic reagents, including drug and drug abuse testing, infectious disease testing, women’s health testing, tumor testing, and heart marker testing. The Company's products are widely used in clinical testing, on-site testing and personal health management, especially in some new drug testing, new coronavirus testing, tropical infectious disease testing, respiratory all-in-one inspection, pediatric diarrhea all-in-one inspection and all-in-one joint inspection of fecal occult blood and other fields. The Company's main business is mainly distributed in overseas regions.
(Source: N-30D)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
2836 Biological products, except diagnostic substances
8731 Commercial physical and biological research
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager FeiGao 49 11/8/2017 11/8/2017
Finance Director, Secretary of the Board YanpingFu 45 11/8/2017 11/8/2017
Deputy General Manager, Director WeikeLu 42 11/8/2017 11/8/2017
3 additional Officers and Directors records available in full report.

General Information
Number of Employees: 1,093 (As of 12/31/2023)
Outstanding Shares: 77,557,701 (As of 9/30/2024)
Shareholders: 5,949
Stock Exchange: SHA
Fax Number: +86 57156267856


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024